Yajin Zhao

Mrs. Yajin Zhao


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Acta Biochimica et Biophysica Sinica
Verified
Journal Article
Closed access
LLLubiao Liang
Lubiao Liang
RSRan Sui
Ran Sui
YSYongxiang Song
Yongxiang Song
YZYajin Zhao
Yajin Zhao
Tumor acidic microenvironment is the main feature of many solid tumors. As a part of the tumor microenvironment, it has a profound impact on the occurrence and development of tumors. However, the research on how tumor cells sense the changes of the external microenvironment and how the intracellular subcellular structures transmit the signals from extracellular to intracellular is unclear. In this study, we identify that the acidic microenvironment enhances cancer cell motility, and the expression of membrane-anchored membrane type 1-matrix metalloproteinase is also associated with cell motility, which indicates more degradation of the ECM under the acidic microenvironment. Moreover, the expression of cofilin is low in the acidic microenvironment, and the F-actin filaments are distributed more along the cells. The cytoskeletal F-actin changes are consistent with the potential of a high-invasive phenotype. Further study reveals the upstream control of the signal transductions from extracellular to intracellular, that is, the integrin β1 functions to trigger the biological responses under the acidic microenvironment. Our results demonstrate that the acidic microenvironment enhances cancer cell motility through the integrin β1/cofilin/F-actin signal axis. This study clearly shows the scheme of the signal transmissions from extracellular to intracellular and further reveals the cytoskeletal roles for the contributions of cancer cell motility under acidic microenvironment, which provides new targets for cancer intervention from the biochemical and biophysical perspectives.

14 September 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
YZYajin Zhao
Yajin Zhao
XWXiang Wang
Xiang Wang
RWRuofeng Wang
Ruofeng Wang
DCDong Chen
Dong Chen
MNMilody Noviana
Milody Noviana
HZHongliang Zhu
Hongliang Zhu

25 April 2025 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
YZYajin Zhao
Yajin Zhao
LLLubiao Liang
Lubiao Liang
AMAbby McCaig
Abby McCaig
TATanroop Aujla
Tanroop Aujla
SKShaf Keshavjee
Shaf Keshavjee
MLMingyao Liu
Mingyao Liu
A recent study demonstrated upregulation of PANoptosis-related genes during reperfusion in human lung transplants. However, the impact of ex vivo lung perfusion (EVLP) on different cell death pathways and their relationship with inflammatory genes and clinical characteristics remains unknown. We conducted transcriptomic analyses on pre- and post-EVLP biopsies from 49 donation after brain death (DBD) and 39 donation after circulatory death (DCD) lungs. Gene set enrichment analysis (GSEA) and single-sample GSEA were used to assess the enrichment of cell death and inflammatory pathways. We further explored the relationships between these pathways, donor characteristics, and clinical outcomes. DBD lungs showed significant enrichment of apoptosis and ferroptosis gene sets compared to DCD lungs. During EVLP, pyroptosis, apoptosis, necroptosis, and ferroptosis gene sets were significantly upregulated and strongly correlated with inflammatory pathways in both DBD and DCD donor lungs. Donor age, sex, and smoking history were associated with specific cell death pathways. In DCD lungs, the expression of ferroptosis-related genes was associated with recipient early outcomes. The expression of cell death gene sets is donor-type specific. The identification of multiple cell death and inflammatory pathways during EVLP provides potential therapeutic targets to improve donor lung quality and enhance clinical outcomes.

17 May 2025 in American Journal of Transplantation
Verified
Journal Article
Open access
LLLubiao Liang
Lubiao Liang
MHMichael K. Hsin
Michael K. Hsin
YZYajin Zhao
Yajin Zhao
AWAizhou Wang
Aizhou Wang
TMTiago Machuca
Tiago Machuca
MLMingyao Liu
Mingyao Liu
Lung transplantation is a cornerstone in treating patients with end-stage lung disease, yet ischemia-reperfusion injury (IRI) poses significant complications in post-transplant recovery. This study aimed to understand the effects of donor type, cold ischemic time (CIT) and the reperfusion on metabolic changes in lung grafts. Porcine donor lungs underwent different CIT on ice: minimal time (control), 6 hours (CIT-6H), and 30 hours (CIT-30H). Additionally, lungs from brain death (BD) animals underwent 24-hour CIT (BD-CIT-24H). Both CIT-30H and BD-CIT-24H lungs underwent ex vivo lung perfusion for 12 hours, followed by left lung transplantation and reperfusion for 2 hours. Lung tissue samples were subjected to metabolomic analysis. Cold preservation induced time-dependent changes of certain metabolites. In BD-CIT-24H group, while most trends in metabolite levels were similar to the CIT-30H group, certain metabolite levels were markedly different. In CIT-30H lungs, reperfusion induced significant changes in the carbohydrate and amino acid pathways, along with consumption of energy substrates and reduction in antioxidants. BD donor lungs exhibited significantly reduction in lysophospholipids after reperfusion. Understanding these metabolic changes in the lung grafts shed lights on the mechanism of IRI, offering valuable insights for future development of targeted strategies to improve donor lung preservation and clinical outcome.

1 July 2014
Verified
Journal Article
Closed access
YXYan-Lian Xiong
Yan-Lian Xiong
YXYan-Lei Xiong
Yan-Lei Xiong
YLYao-Jin Li
Yao-Jin Li
FTFuzhou Tang
Fuzhou Tang
RWRuo-Feng Wang
Ruo-Feng Wang
XWXiang Wang
Xiang Wang

19 April 2025
Verified
Book Chapter
Open access
PDF file
LLLubiao Liang
Lubiao Liang
YZYajin Zhao
Yajin Zhao
Curcumin, a polyphenolic compound derived from the turmeric plant (Curcuma longa), has garnered significant attention for its potential anticancer properties due to its ability to modulate multiple molecular targets involved in cancer development and progression. This chapter provides a comprehensive overview of curcumin’s mechanisms of action in cancer therapy, focusing on its effects on cell proliferation, apoptosis, metastasis, and inflammation. Curcumin exerts its anticancer effects through various signaling pathways, including the suppression of NF-κB, JAK/STAT3, and PI3K/Akt, and the modulation of cell cycle regulators. Despite its promising anticancer potential, curcumin faces challenges in clinical applications due to its poor bioavailability, low solubility, and rapid metabolism. To overcome these limitations, innovative drug delivery systems, such as nanoparticles, liposomes, and polymer-based formulations, have been developed to enhance curcumin’s therapeutic efficacy and stability. These systems improve the solubility, targeted delivery, and controlled release of curcumin, thereby maximizing its anticancer effects while minimizing systemic toxicity. Moreover, preclinical and clinical studies assessing curcumin’s clinical potential in combination with other chemotherapeutic agents and its role as an adjuvant in cancer treatment have shown promising results. The chapter concludes by discussing the challenges and future directions of curcumin-based therapies, including the need for further clinical trials to establish optimal dosage, formulation, and therapeutic regimens and the potential for curcumin to be integrated into personalized cancer treatments.